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1  | INTRODUC TION
The criteria applied for diagnosis of left atrial (LA) abnormality using 
electrocardiogram (ECG) are based on various parameters includ-
ing	P-wave	duration	≥	120	ms,	 the	classic	Morris	 index	 (increase	 in	
P-wave terminal force in V1 [PtfV1],	 with	 terminal	 negativity	 of	 P	
wave in V1	<	−0.1	mV	and	duration	>0.04	s)	(Morris,	Estes,	Whalen,	
&	Thompson,	1964),	P-wave	morphology	 in	 inferior	 leads,	P	voltage	
in	lead	I,	P-wave	area/axis,	and	P-wave	score(Alexander	et	al.,	2019).	
These	 criteria	 have	 high	 specificity	 (85%–90%)	 but	 low	 sensitivity	
(Josephson,	Kastor,	&	Morganroth,	1977;	Tsao	et	al.,	2008;	Bayes	de	
Luna,	2012)	and	can	also	be	used	for	diagnosis	of	interatrial	block	(IAB).	
Therefore,	a	consensus	statement	of	the	American	Heart	Association	
suggests	 including	 these	 P-wave	 changes,	 whether	 due	 to	 LA	
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Abstract
Background: The criteria applied for diagnosis of left atrial (LA) abnormality using 
electrocardiogram	(ECG)	have	high	specificity	but	low	sensitivity.	In	fact,	some	au-
thors have suggested classifying P-wave anomalies associated with LA abnormality 
and	 interatrial	block	as	 “atrial	abnormalities.”	The	most	widely	known	ECG	criteria	
for	LA	abnormality	include	P-wave	duration,	morphology	and	voltage	of	P	wave	in	
inferior	leads,	presence	of	P-wave	terminal	force	in	V1 (PtfV1),	and	P-wave	axis	and	
area. PtfV1 has also been reported to vary according to misplacement of the V1 and 
V2 electrodes.
Methods: The objective of this observational cohort study is to determine the degree 
of correlation between ECG criteria for LA abnormality and left atrium volume and 
functionality,	as	determined	by	speckle	 tracking	echocardiography.	The	study	also	
aims to investigate the correlation between these echocardiographic parameters and 
PtfV1 value by placing the V1 and V2	electrodes	in	the	second,	third,	and	fourth	in-
tercostal spaces.
Results and Conclusions: Our results could help to clarify whether the decrease in 
left	atrial	deformity,	which	is	currently	considered	a	surrogate	target	of	fibrosis,	cor-
relates better with ECG criteria for LA abnormality than atrial volumes.
K E Y W O R D S
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abnormality	or	IAB,	as	"P-wave	abnormalities"	(Hancock	et	al.,	2009).	
Furthermore,	young	athletes	might	have	LA	abnormality	with	P-wave	
duration	 <	 120	 ms	 (Hock	 et	 al.,	 2019).	 The	 Morris	 index	 (Morris	
et	al.,	1964),	which	is	the	only	criterion	with	acceptable	sensitivity,	was	
recently	shown	to	be	unreliable	(Sajeev	et	al.,	2019).	Furthermore,	the	
negativity	of	the	P	wave	increases	(Rasmussen	et	al.,	2019)	if	the	V1 
electrode	is	placed	in	the	second	intercostal	space.	Some	authors	have	
suggested that this V1 pattern represents no more than an interatrial 
conduction defect and may not necessarily indicate LA abnormality 
(Josephson	et	al.,	1977).
The main aim of our observational study is to compare the as-
sociation between P-wave criteria in patients with LA abnormality 
on	transthoracic	echocardiography	(TTE).	As	secondary	objectives,	
we aim to study the association between P-wave criteria in patients 
with	 left	 atrium	 (LA)	 functional	 abnormalities	 on	 speckle	 tracking	
echocardiography	(STE).	In	addition,	we	will	analyze	the	correlation	
between these echocardiographic parameters and PtfV1 value by 
placing the V1 and V2	electrodes	in	the	second,	third,	and	fourth	in-
tercostal spaces.
2  | METHODS
2.1 | Design and study population
We	will	 perform	 a	 prospective	 observational	 cohort	 study	 in	 the	
Echocardiography and Non-invasive Cardiology Laboratory of the 
Hospital	Universitario	de	Canarias.	The	study	population	will	com-
prise patients referred for TTE (Figure 1).
2.2 | Inclusion criteria
•	 Age	≥	60	years.
•	 Signed	informed	consent.
• Optimal-quality ECG and echocardiography images.
2.3 | Exclusion criteria
• Poor transthoracic window.
• Atrial fibrillation (all types).
• Previous arrhythmias (atrial and ventricular).
• Absence of measurable P waves.
• Cardiac devices.
•	 Chest	 abnormalities	 (including	 pectus	 excavatum	 and	 straight	
back	syndrome).
• Chronic obstructive pulmonary disease.
2.4 | P-wave parameters
The ECGs will be obtained according to the standards set at 25 mm/s 
and	10	mm/mv,	with	a	filtering	range	of	0.05–150	Hz	and	AC	filter	at	
F I G U R E  1  Study	design.	A-IAB,	advanced	interatrial	block;	PtfV1,	P	terminal	force	V1
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50	Hz.	In	addition,	the	branch	position	of	the	V1 and V2 electrodes 
will be intentionally varied in 3 successive ECGs (position in the 
fourth,	third,	and	second	intercostal	space;	Figure	2)
.	The	ECGs	will	be	analyzed	by	2	experienced	cardiologists	(VB	
and	MMS),	who	will	be	blinded	to	the	TTE	and	STE	data.	The	P-wave	
duration will be measured in the frontal plane leads in digital ECG 
(amplified	20	times)	using	GeoGebra	4.2	software.	The	interval	be-
tween the earliest and the latest detection of atrial depolarization 
will be used. The following ECG parameters will be included to eval-
uate	LA	and	right	atrial	 (RA)	abnormalities	 (Alexander	et	al.,	2019;	
Hancock	et	 al.,	 2009;	Kaplan,	Evans,	Foster,	 Lim,	&	Schiller,	1994;	
Lee	et	al.,	2007;	Tsao	et	al.,	2008).
ECG parameters for assessment of LA abnormality:
1.	 P-wave	 duration	 (<120	 ms,	 120–140	 ms,	 >140	 ms)
2. P-wave morphology in the inferior leads (nonbiphasic or biphasic)
3. Presence of PtfV1
4.	 P	voltage	in	lead	I	(>0.20	mV,	0.10–0.20	mV,	<0.10	mV)
5.	 P-wave	area	and	axis
6.	 P-wave	MVP	score
7.	 Length	of	the	P	wave	in	lead	II	>	120	ms
8.	 Left	deviation	of	the	middle	axis	of	the	P	wave	between	−30	and	
−45º.
The ECG criteria for diagnosing RA abnormality are as follows:
1.	 P-wave	 amplitude	 in	 lead	 II	 >	 2.5	 mm.
2.	 Upward	deflection	of	the	P	wave	in	lead	V1	>	1.5	mm	in	amplitude.
3. Increase of the area under the initial positive part of the P wave in 
V1	>	0.06	mm-s.
4.	 Right	deviation	of	the	middle	axis	of	the	P	wave	greater	than	+75º.
2.5 | Echocardiography studies
Echocardiography studies will be stored digitally and will be an-
alyzed	by	2	experienced	operators	 (JLA	and	MMIG),	who	will	 be	
blinded to the clinical ECG data. The operators will use a com-
mercial	 system	 (iE33	 xMATRIX,	 Koninklijke	 Philips	 NV)	 with	 a	
2–4	MHz	multifrequency	transducer.	Three	consecutive	beats	will	
be recorded in a cineloop format during apnea. The analysis will 
be	performed	using	an	echocardiographic	analysis	system	(Xcelera	
R2,	Philips).	LA	and	left	ventricular	(LV)	measurements	and	LV	ejec-
tion fraction and Doppler variables will be measured to quantify LV 
diastolic function according to standard echocardiographic meth-
ods	 (Nishimura	&	 Tajik,	 1997)	 (Table	 1).	 The	maximal	 LA	 volume	
(LAV	max)	will	be	traced	in	both	the	apical	4-	and	2-chamber	views	
in	the	“frame”	prior	to	mitral	valve	opening	using	the	biplane	disk	
summation	algorithm	to	calculate	its	volume,	adjusted	for	body	sur-
face	area	and	considering	an	LAmax	>	34	ml/m2 as increased (Lang 
et	al.,	2015).	The	size	of	the	RA	will	be	quantified	using	the	apical	
four-chamber	view,	 and	 the	volume	will	 be	determined	using	 the	
disk	summation	technique	in	2D	mode	(Lang,	et	al.,	2015).
For	 the	 STE	 of	 the	 LA,	 standard	 2D	 images	 from	 apical	 4-	 and	
2-chamber	views	will	be	acquired,	with	a	narrow	sector	angle	(30°–60°)	
and	a	frame	rate	of	60–90	frames	per	second	(Badano	et	al.,	2018).	The	
LA	endocardial	border	will	be	traced	manually	in	both	4-	and	2-chamber	
views	by	marking	2	points	at	both	ends	of	the	mitral	annulus	and	a	third	
at the ceiling of the LA in end systole. The surface epicardial tracing is 
automatically generated by the system and can be adjusted manually 
by	the	operator	in	cases	of	tracking	failure.	Any	segments	that	subse-
quently	fail	to	track	will	be	excluded.	The	LA	myocardium	will	be	divided	
into	12	segments	of	interest.	For	analysis,	a	longitudinal	strain	and	strain	
rate	 (SR)	will	be	measured	automatically	“offline”	 (Yasuda	et	al.,	2015)	
using	QLAB	Advanced	 Tissue	Motion	Quantification	 (Philips)	 Release	
8.1	equipped	with	STE	analysis	software.	Global	longitudinal	strain	and	
SR	will	be	the	average	of	the	12	values	obtained	for	each	LA	segment	
(Table 1). Zero strain reference will be set at LV end diastole or when the 
LA	speckle	tracking	is	triggered	on	QRS	onset	(Badano	et	al.,	2018),(Olsen 
et	al.,	2016).	The	periods	of	the	cardiac	cycle	will	be	determined	after	ob-
taining	the	LA	longitudinal	strain/SR	and	aligning	them	with	the	pulsed	
Doppler	spectrum	of	the	LV	inflow	and	outflow	tracts,	starting	at	QRS	
onset	(Badano	et	al.,	2018),(Olsen	et	al.,	2016).	RA	deformation	will	be	
assessed in the apical four-chamber view in 2D by starting the tracing at 
the endocardial border of the RA in the tricuspid annulus and continuing 
along	the	lateral	wall	of	the	RA,	roof	of	the	RA,	and	septal	wall	of	the	RA,	
before finishing at the opposite border of the tricuspid annulus. The api-
cal	four-chamber	view	will	be	optimized	by	avoiding	RA	foreshortening,	
thus	enabling—as	with	the	LA—the	volumes,	strain,	and	strain	rate	of	the	
RA	to	be	determined	(Badano	et	al.,	2018).
F I G U R E  2  V1	lead	of	a	healthy	patient	with	normal	left	atrial	size	for	echocardiography,	with	the	V1	electrode	located	in	the	correct	
place:	fourth	intercostal	space	(4),	third	intercostal	space	(3),	and	second	intercostal	space	(2).	Note	how	a	normal	P	wave	becomes	
progressively negative as the V1 electrode is located upward
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2.6 | Other variables
Sociodemographic	 variables,	 presence	 of	 comorbidities,	 pharma-
cological	 treatments,	 and	 indications	 for	 echocardiography	will	 be	
recorded (Table 2).
2.7 | Sample size calculation
Previous	 data	 suggested	 that	 92%	of	 patients	with	 LA	 abnormality	
might	have	a	positive	Morris	index	(Morris	et	al.,	1964).	We	estimate	
that	79	patients	with	a	positive	Morris	index	are	required	to	determine	
this	rate	with	a	confidence	level	of	95%	and	precision	error	of	6%.
2.8 | Statistical analysis
Continuous variables will be compared using the t	 test	or	 the	Mann–
Whitney	test.	Categorical	variables	will	be	compared	using	the	chi-square	
test.	Based	on	the	volume	of	LAV	max	by	echocardiography,	2	groups	
will	 be	 established,	 as	 follows:	 increased	 volume	 and	 normal	 volume.	
Correlations	between	ECG	and	TTE	STE	variables	will	be	obtained	using	
the	Spearman	rank	test	and	the	intraclass	correlation	coefficient.	We	will	
use	the	logistic	regression	model	adjusted	for	potential	confounders,	in-
cluding variables that are significant in the univariate model. The ability 
of	the	multivariate	logistic	model	to	correlate	with	the	LAV	max	group	
will be verified using receiver operating characteristic (ROC) curves. The 
overall	 accuracy,	 sensitivity,	 specificity,	 and	positive	 and	negative	pre-
dictive	values	for	the	optimal	cutoff	will	be	calculated	using	the	Youden	
index.	Intra-	and	interobserver	variability	will	be	assessed	using	Bland–
Altman	analysis.	All	statistical	analyses	will	be	performed	using	IBM	SPSS	
Statistics	for	Windows,	Version	23	(IBM	Corp.,	Armonk,	NY,	USA).
2.9 | Ethical considerations
This study will be reviewed and approved by the Clinical Research 
Ethics	 Committee	 of	 Hospital	 Universitario	 de	 Canarias.	 All	
TA B L E  1   Doppler echocardiography with atrial strain variables
LAmin,	BS	(ml/m2)
LAmax,	BS	(ml/m2)
LAVpre,	BS	(ml/m2)
Anteroposterior	diameter	measurement	of	left	atrium	in	long	axis	
parasternal	in	2D,	mm
LAEF,	%
LAEF	passive,	%
LAEF	active,	%
LASr,	%
LAScd,	%
LASct,	%
pLASRr,	1/s
pLASRcd,	1/s
pLASRct,	1/s
Pulsed	mitral	Doppler:	E	wave,	cm/sec
Pulsed	mitral	Doppler:	A	wave,	cm/sec
E/A ratio
E-wave	deceleration	time,	msec
A-wave	duration,	msec
Pulsed	Doppler	pulmonary	vein	PVs,	cm/sec
Pulsed	Doppler	pulmonary	vein	PVd,	cm/sec
S/D	ratio
Mitral	annular	tissue	Doppler:	e´	septal,	cm/sec
Mitral	annular	tissue	Doppler:	a ,´	septal,	cm/sec
Mitral	annular	tissue	Doppler:	s ,´	septal,	cm/sec
Mitral	annular	tissue	Doppler:	e ,´	lateral,	cm/sec
Mitral	annular	tissue	Doppler:	a ,´	lateral,	cm/sec
Mitral	annular	tissue	Doppler:	s ,´	lateral,	cm/sec
E/e´	ratio
Vp,	cm/sec
E mitral/Vp ratio.
LVED	dimension,	mm
LVES	dimension,	mm
LVED	volume	index,	ml/m2
LVES	volume	index,	ml/m2
Relative	wall	thickness
Left	ventricular	mass	index,	g/m2
Left	ventricular	ejection	fraction,	biplane	(%)
RA volume (ml/m2)
RASr,	%
(Continues)
RAScd,	%
RASct,	%
pRASRr,	1/s
pRASRcd,	1/s
pRASRct,	1/s
Abbreviations:	BS,	body	surface;	LAEF,	total	left	atrial	emptying	
fraction;	LAmax,	maximum	volume	of	left	atrium;	LAmin,	minimum	
volume	of	left	atrium;	LAScd,	left	atrial	strain	during	conduit	phase;	
LASct,	left	atrial	strain	during	contraction	phase;	LASr,	left	atrial	strain	
during	reservoir	phase;	LAVpre,	left	atrium	volume	at	the	beginning	of	
the	P	wave	of	the	ECG;	LVED,	left	ventricular	end-diastolic;	LVES,	left	
ventricular	end-systolic;	pLASRcd,	left	atrial	peak	strain	rate	during	
conduct	phase;	pLASRct,	left	atrial	peak	strain	rate	during	contraction	
phase;	pLASRr,	left	atrial	peak	strain	rate	during	reservoir	phase;	
pRASRcd,	(negative)	peak	strain	rate	during	conduit	phase;	pRASRct,	
(negative)	peak	strain	rate	during	contraction	phase;	pRASRr,	(positive)	
peak	strain	rate	during	reservoir	phase;	PVd,	pulsed	Doppler	pulmonary	
vein,	diastole	pulmonary	vein;	PVs,	pulsed	Doppler	pulmonary	vein,	
systole	pulmonary	vein;	RA,	right	atrial;	RAScd,	strain	during	conduit	
phase;	RASct,	strain	during	contraction	phase;	RASr,	strain	during	
reservoir	phase;	Vp,	M	mode	color,	left	intraventricular	propagation	
velocity.
TA B L E  1   Continued
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participants will be informed about the aims and procedures of the 
project and will sign a written informed consent document. The 
project	will	be	conducted	 in	accordance	with	the	World	Medical	
Association	Declaration	of	Helsinki	related	to	Ethical	Principles	for	
Medical	Research	 Involving	Human	Subjects,	 the	Convention	on	
Human	Rights	and	Biomedicine	of	 the	Council	of	Europe	 (1997),	
and	the	Additional	Protocol	to	the	Convention	on	Human	Rights	
and	Biomedicine,	concerning	Biomedical	Research	(2005).
2.10 | Study timeline
The	study	is	expected	to	begin	in	June	2020.	The	estimated	end	of	
the	inclusion	period	is	July	2020,	and	the	estimated	completion	date	
for	the	study	is	September	2020.
3  | CONCLUSION
Our prospective observational study will help to define ECG cri-
teria	 for	 LA	 and	 RA	 abnormality	 and	 to	 distinguish	 IAB	 from	 LA	
abnormality.
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Demographic variables
Age
Sex
Height,	cm
Weight,	kg
BMI,	kg/m2
BSA,	m2
Diabetes mellitus
Smoking
Hypertension
Hyperlipidemia
TIA	or	previous	stroke
Previous diagnosis of heart failure
Known	coronary	artery	disease
Obstructive sleep apnea
CHADS2 score
CHA2DS₂-VASc	score
ACE	inhibitors/ARBs
Beta	blockers
Anticoagulants or NOACs
Antiplatelet agents
Antiarrhythmic agents
Indications for echocardiography study
Chest pain
Coronary artery disease
Valvulopathy
Cardiomyopathy
LVEF calculation
Dyspnea
Murmur
Syncope
Hypertension
Rule out structural heart disease
Pulmonary hypertension
Aortic aneurysm
Abbreviations:	ACE,	angiotensin-converting	enzyme;	ARBs,	angiotensin	
II	receptor	blockers;	BMI,	body	mass	index;	BSA,	body	surface	area;	
LVEF,	left	ventricular	ejection	fraction;	NOACs,	new	oral	anticoagulant	
agents;	TIA,	transitory	ischemic	attack.
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